ijms-logo

Journal Browser

Journal Browser

Role of NLRP3 in Inflammation and Tumour

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (20 November 2023) | Viewed by 1179

Special Issue Editor


E-Mail Website
Guest Editor
School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS 7250, Australia
Interests: gut health; mucosal immunology; IBD; colitis; colorectal cancer; probiotic; prebiotics

Special Issue Information

Dear Colleagues,

Investigations of various inflammatory mechanisms have pointed to a major role for inflammasomes which are multi-molecular complexes and potent inducers of immunity. Inflammasomes such as NLR Pyrin Domain Containing 3 (NLRP3), produce the inflammatory cytokines IL-1β and IL-18 and are implicated in both inflammation and cancer. Depending on the context of models and setting utilised, the role assigned for NLRP3 in both inflammation and cancer varies from pro to anti-inflammatory and from tumour suppression to tumour causation. The aim of this Special Issue is to bring about the latest thinking in terms of roles played by NLRP3 in health and disease with a particular focus on inflammation and cancer.

Dr. Rajaraman Eri
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • NLRP3
  • inflammation
  • inflammasomes
  • tumour

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

43 pages, 2771 KiB  
Review
Unraveling the Role of the NLRP3 Inflammasome in Lymphoma: Implications in Pathogenesis and Therapeutic Strategies
by Ioanna E. Stergiou, Christos Tsironis, Stavros P. Papadakos, Ourania E. Tsitsilonis, Meletios Athanasios Dimopoulos and Stamatios Theocharis
Int. J. Mol. Sci. 2024, 25(4), 2369; https://doi.org/10.3390/ijms25042369 - 17 Feb 2024
Viewed by 849
Abstract
Inflammasomes are multimeric protein complexes, sensors of intracellular danger signals, and crucial components of the innate immune system, with the NLRP3 inflammasome being the best characterized among them. The increasing scientific interest in the mechanisms interconnecting inflammation and tumorigenesis has led to the [...] Read more.
Inflammasomes are multimeric protein complexes, sensors of intracellular danger signals, and crucial components of the innate immune system, with the NLRP3 inflammasome being the best characterized among them. The increasing scientific interest in the mechanisms interconnecting inflammation and tumorigenesis has led to the study of the NLRP3 inflammasome in the setting of various neoplasms. Despite a plethora of data regarding solid tumors, NLRP3 inflammasome’s implication in the pathogenesis of hematological malignancies only recently gained attention. In this review, we investigate its role in normal lymphopoiesis and lymphomagenesis. Considering that lymphomas comprise a heterogeneous group of hematologic neoplasms, both tumor-promoting and tumor-suppressing properties were attributed to the NLRP3 inflammasome, affecting neoplastic cells and immune cells in the tumor microenvironment. NLRP3 inflammasome-related proteins were associated with disease characteristics, response to treatment, and prognosis. Few studies assess the efficacy of NLRP3 inflammasome therapeutic targeting with encouraging results, though most are still at the preclinical level. Further understanding of the mechanisms regulating NLRP3 inflammasome activation during lymphoma development and progression can contribute to the investigation of novel treatment approaches to cover unmet needs in lymphoma therapeutics. Full article
(This article belongs to the Special Issue Role of NLRP3 in Inflammation and Tumour)
Show Figures

Figure 1

Back to TopTop